Drug Approval Package
  • Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Drug Approval Package

  • Print
  • Share
  • E-mail
-

Triesence (Triamcinolone Acetonide) Injectable Suspension
Company: Alcon Research, Ltd.
Application No.:  022048 & 022223
Approval Date: 11/29/2007

 

Date created: July 8, 2008

Back to Top    Drugs@FDA

 

Note: Documents in PDF format require the Adobe Acrobat Reader®.

-
-